Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000912057-02-021277
Filing Date
2002-05-20
Accepted
2002-05-20 11:18:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G a2080590zsc13g.txt SC 13G 6303
  Complete submission text file 0000912057-02-021277.txt   8275
Mailing Address 30 ROWES WHARF BOSTON MA 02110
Business Address 30 ROWES WHARF BOSTON MA 02110 6175740537
H&Q HEALTHCARE INVESTORS (Filed by) CIK: 0000805267 (see all company filings)

EIN.: 046564285 | State of Incorp.: MA | Fiscal Year End: 0930
SIC: 0000

Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Subject) CIK: 0000913275 (see all company filings)

EIN.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-45862 | Film No.: 02657187
SIC: 2833 Medicinal Chemicals & Botanical Products